NCT00004151View on ClinicalTrials.gov

Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

November 30, 2000

Conditions
Lung Cancer
Interventions
DRUG

acridine carboxamide

Trial Locations (8)

2100

Rigshospitalet, Copenhagen

13385

CHU de la Timone, Marseille

21079

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon

28041

Hospital Universitario 12 de Octubre, Madrid

80131

Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples

A-1100

Kaiser Franz Josef Hospital, Vienna

D-80639

Haemato-Onkologische Praxis und Tagesklinik, Munich

00161

Istituti Fisioterapici Ospitalieri - Roma, Rome

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00004151 - Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter